Prescription drugs
Video: Advances in Investigative Techniques: Drug Monitoring Programs
Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants
Responding to the Opioid Crisis in Rural America: Judges and Sheriffs Workshop, Meeting Summary
Best Practices for Successful Reentry for People Who Have Opioid Addictions
The Clinician-Patient Working Alliance: Is It a Significant Predictor of Psychiatric Medication Adherence in a Sample of Recently Released Parolees
Concomitant Use of Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder and Benzodiazepines: Using the Prescription Behavior Surveillance System
Psychosocial Correlates of Clinicians Prescription Drug Monitoring Program Utilization
Law Enforcement Officers' Perceptions of Florida's Prescription Drug Monitoring Program
Office of Justice Programs (OJP) / Centers for Disease Control (CDC) Federal Medicolegal Death Investigation Interagency Working Group (MDI-IWG) Resource Page
The Department of Justice’s (DOJ) Office of Justice Programs (OJP) and the Department of Health and Human Services’ (HHS) Center for Disease Control and Prevention (CDC) established this Federal Medicolegal Death Investigation (MDI) Interagency Working Group (MDI-IWG) to coordinate Federal initiatives to strengthen the MDI system and support death investigation services practiced by medical examiner and coroner offices (ME/Cs) across the United States. The MDI-IWG...
Fatal Poisonings Involving Propoxyphene Before and After Voluntary Withdrawal From the United States Market: An Analysis From the State of Florida
Law Enforcement Resources
OJP, along with DOJ partners, are committed to supporting and protecting America's law enforcement. Featured resources include officer safety & wellness, DOJ resources, VALOR, tribal law enforcement, and helping law enforcement combat opioids.